Prostate Cancer and the Hypofractionation Hypothesis

被引：26
|
作者：
Lee, W. Robert [1 ]
机构：
[1] Duke Univ, Sch Med, Durham, NC 27708 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 31期
关键词：
RADIATION-THERAPY; RADIOTHERAPY; FRACTION; TRIAL; GY;
D O I：
10.1200/JCO.2013.52.4942
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3849 / 3851
页数：3
相关论文
共 50 条
  • [41] Hypofractionation in Prostate Cancer: How Far Can We Go?
    Hoskin, P. J.
    CLINICAL ONCOLOGY, 2008, 20 (10) : 727 - 728
  • [42] Dose constraints validation in moderate hypofractionation in localized prostate cancer
    Maldonado, X.
    Altabas, M.
    Garre, J.
    Vazquez, M.
    Magrina, S.
    Delgado, A.
    Docampo, N.
    Geng, A.
    Hermida, M.
    Sanchez-Artuno, D.
    Giralt, J.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S1113 - S1114
  • [43] Investigating the Benefit of Combined Androgen Modulation and Hypofractionation in Prostate Cancer
    Zamagni, Alice
    Zanoni, Michele
    Cortesi, Michela
    Arienti, Chiara
    Pignatta, Sara
    Naldini, Antonella
    Sarnelli, Anna
    Romeo, Antonino
    Tesei, Anna
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (22) : 1 - 17
  • [44] Moderate or extreme hypofractionation and localized prostate cancer: The times are changing
    Krhili, S. Line
    Crehange, G.
    Albert-Dufrois, H.
    Guimas, V.
    Minsat, M.
    Supiot, S.
    CANCER RADIOTHERAPIE, 2019, 23 (6-7): : 503 - 509
  • [45] Hypofractionation Adoption in Prostate Cancer Radiotherapy: Results of an International Survey
    Sabbagh, Ali
    Weiss, Jessica
    Tawk, Bouchra
    Mohammed, Mohammed A.
    Abdulbaki, Hasan
    Moraes, Fabio Y.
    Grover, Surbhi
    Yap, Mei Ling
    Zubizarreta, Eduardo
    Lievens, Yolande
    Rodin, Danielle
    Mohamad, Osama
    JCO GLOBAL ONCOLOGY, 2023, 9
  • [46] Toxicity Profile in Postoperative Radiotherapy for Prostate Cancer with Moderate Hypofractionation
    Pacifico, P.
    Bonetto, E. M.
    Niespolo, R. M.
    De Ponti, E.
    Vukcaj, S.
    Arcangeli, S.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S610 - S610
  • [47] Does sufficient evidence exist to support hypofractionation for prostate cancer?
    Carlone, M
    Wilkins, D
    Raaphorst, P
    RADIOTHERAPY AND ONCOLOGY, 2004, 72 : S15 - S15
  • [48] Hypofractionation Adoption in Prostate Cancer Radiotherapy: Results of an International Survey
    Sabbagh, Ali
    Weiss, Jessica
    Tawk, Bouchra
    Mohammed, Mohammed A.
    Abdulbaki, Hasan
    Moraes, Fabio Y.
    Grover, Surbhi
    Yap, Mei Ling
    Zubizarreta, Eduardo
    Lievens, Yolande
    Rodin, Danielle
    Mohamad, Osama
    JCO GLOBAL ONCOLOGY, 2023, 9 : e2300046
  • [49] Moderate hypofractionation radiotherapy with helical tomotherapy (HT) for prostate cancer
    Ferrera, G.
    Mortellaro, G.
    Caminiti, G.
    Mazzola, R.
    Spera, A.
    Grillo, A.
    Di Paola, G.
    Cucchiara, T.
    Sciume, F.
    Messana, D.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S91 - S92
  • [50] Flattening Filter Free VMAT for extreme hypofractionation of prostate cancer
    Ahlstrom, M.
    Benedek, H.
    Nilsson, P.
    Knoos, T.
    Ceberg, C.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S407 - S408
12345